Close Menu

Sustained Increase of Serum Creatine Phosphokinase Levels and Progressive Muscle Abnormalities Associated with Raltegravir Use during 32-week Follow-up in an HIV-1 Experienced Patient on Simplified HAART Regimen, Intolerant to PIs and Abacavir: A Case Rep

Issue: 
DOI: 
10.7727/wimj. 2011.193
Pages: 
377–9

ABSTRACT


Sustained increase of serum creatine phosphokinase (CPK) concentrations and muscle abnormalities have been reported in patients taking raltegravir (RAL). In this report, we describe a case of sustained and asymptomatic increase of serum CPK concentrations associated with raltegravir, zidovudine, and lamivudine in an HIV-1 experienced patient with intolerance to protease inhibitor, abacavir and pencillin during 32 weeks of continuous drug monitoring.

PDF Attachment: 
e-Published: 14 Aug, 2013
Top of Page